Detalles de la búsqueda
1.
Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
Pediatr Blood Cancer
; 70(4): e30204, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715125
2.
A simple procedure to identify children with B-lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single-point minimal residual disease measurement.
Pediatr Blood Cancer
; 70(6): e30295, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36975157
3.
Incidence and prognostic value of central nervous system involvement in infants with B-cell precursor acute lymphoblastic leukemia treated according to the MLL-Baby protocol.
Pediatr Blood Cancer
; 69(9): e29860, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35713168
4.
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.
Cancer Med
; 13(8): e7172, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38651186
5.
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study.
J Cancer Res Clin Oncol
; 149(8): 4629-4637, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169717
6.
A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL.
Cancers (Basel)
; 15(23)2023 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067249
7.
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results.
Leukemia
; 36(5): 1382-1385, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322171
8.
A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008.
Leuk Res
; 123: 106982, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332292
9.
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols.
Leukemia
; 34(11): 3042-3046, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533093
Resultados
1 -
9
de 9
1
Próxima >
>>